TCL Archive Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho October 26, 2012
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive ASCO Survey Finds Practice Expenses 90% Higher Than Medicare Assumptions October 11, 2002
